Table 5 Observed overall incidence rates of tuberculosis in the abatacept CDP and RA cohorts
Cohort | Tuberculosis IR/100 py (95% CI) |
|---|---|
Observed IR | Â |
   DB Abatacept Population | 0.06 (0.0 to 5.6) |
   DB Placebo Population | 0.13 (0.0 to 5.6) |
   Cumulative Abatacept Population (DB + OL)** | 0.04 (0.01 to 0.10) |
Expected IR | Â |
   BC | 0.03 (0.01 to 0.05) |
   NDB | 0.02 (0.01 to 0.04) |
   PharMetrics | 0.02 (0.01 to 0.04) |
   NOAR | 0.013* |
   Sweden ERA | 0.026 (0.003 to 0.094) |
   Sweden INPT | 0.05 (0.04 to 0.06) |